Prognostic factors in ductal carcinoma in situ;Prognostische faktoren beim duktalen carcinoma in situ

Pathologe

Volumn 27, Issue 5, 2006, Pages 326-336

  Lebeau, A ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Breast cancer; Ductal carcinoma in situ (DCIS); Microinvasion; Pseudoinvasion

Indexed keywords

TAMOXIFEN;

ARTICLE; BREAST CANCER; CARCINOMA IN SITU; CLINICAL FEATURE; HUMAN; INVASIVE CARCINOMA; PROGNOSIS;

CALCINOSIS; CARCINOMA, DUCTAL, BREAST; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; NEOPLASM INVASIVENESS; PROGNOSIS;

EID: 33748644214     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-006-0853-y     Document Type: Article

References (31)

1. Badve S, A'Hern RP, Ward AM et al. (1998) Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up. Hum Pathol 29: 915-923
2. Bässler R (1997) Mamma. In: Remmele W (Hrsg) Pathologie, Bd 4. Springe, Berlin Heidelberg New York Tokyo, S
3. Bijker N, Peterse JL, Duchateau L et al. (2001) Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 19: 2263-2271
4. Blamey RW, Macmillan RD, Rampaul RS et al. (2002) Ductal carcinoma in situ: experience at Nottingham City Hospital 1973 through 2000. In: Silverstein MJ (ed) Ductal carcinoma in situ of the breast. Lippincott Williams & Wilkins, Philadelphia, pp 322-328
5. Consensus Conference Committee (1997) Consensus Conference on the classification of ductal carcinoma in situ. Cancer 80: 1798-1802
6. EC Working Group on Breast Screening Pathology (2001) Quality assurance guidelines for pathology in mammography screening - non-operative diagnosis. In: Perry N, Broders M, de Wolf C et al. J (eds) European guidelines for quality assurance in mammography screening. Office for Official Publications of the European Communities, Luxembourg, pp 159-172
7. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410
8. Fisher ER, Dignam J, Tan-Chiu E et al. (1999) Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 86: 429-438
9. Frykberg ER, Bland KI (1994) Overview of the biology and management of ductal carcinoma in situ of the breast. Cancer 74: 350-361
10. Kreienberg R, Kopp I, Lorenz W et al. (2004) Interdisziplinäre S3-Leitlinie für die Diagnostik und Therapie des Mammakarzinoms der Frau. Zuckschwerdt, München
11. Lagios MD (1990) Duct carcinoma in situ. Pathology and treatment. Surg Clin North Am 70: 853-871
12. Lagios MD (2002) Practical pathology of duct carcinoma in situ: how to derive optimal data from the pathologic examination. In: Silverstein MJ (ed) Ductal carcinoma in situ of the breast. Lippincott Williams & Wilkins, Philadelphia, pp 207-221
13. Lebeau A, Böcker W, Bürrig KF et al. (2003 a) Anleitung Mammapathologie. In: Schulz KD, Albert US (Hrsg) Stufe-3-Leitlinie Brustkrebsfrüherkennung in Deutschland. Zuckschwerdt, München, S 179-204
14. Lebeau A, Unholzer A, Amann G et al. (2003 b) EG-FR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast. Breast Cancer Res Treat 79: 187-198
15. Leonard GD, Swain SM (2004) Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 96: 906-920
16. NHSBSP, Guidelines Working Group of the National Coordinating Committee for Breast Pathology (2005) Pathology reporting of breast disease. NHS Screening Programmes and The Royal College of Pathologists. NHSBSP Publication No. 58, Sheffield
17. Page DL, Rogers LW (1992) Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol 23: 1095-1097
18. Page DL, Dupont WD, Rogers LW et al. (1995) Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 76: 1197-1200
19. Rosai J (1991) Borderline epithelial lesions of the breast. Am J Surg Pathol 15: 209-221
20. Sanders ME, Schuyler PA, Dupont WD, Page DL (2005) The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 103: 2481-2484
21. Schnitt SJ, Connolly JL, Tavassoli FA et al. (1992) Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 16: 1133-1143
22. Silverstein MJ (2003) The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg 186: 337-343
23. Silverstein MJ, Buchanan C (2003) Ductal carcinoma in situ: USC/Van Nuys Prognostic Index and the impact of margin status. Breast 12: 457-471
24. Silverstein MJ, Lagios MD, Craig PH et al. (1996) A prognostic index for ductal carcinoma in situ of the breast [see comments]. Cancer 77: 2267-2274
25. Singletary SE (2002) Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 184: 383-393
26. Sloane JP (2001) Biopsy pathology of the breast. Arnold, London
27. Sloane JP, Ellman R, Anderson TJ et al. (1994) Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U.K. National Coordinating Group for Breast Screening Pathology. Eur J Cancer 30A: 1414-1419
28. UICC (2002) TNM classification of malignant tumours. Wiley-Liss, New York
29. Wells WA (2002) The diagnostic reproducibility of ductal carcinoma in situ. In: Silverstein MJ (ed) Ductal carcinoma in situ of the breast. Lippincott Williams & Wilkins, Philadelphia, pp 264-272
30. WHO/Tavassoli FA, Devilee P (eds) (2003) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC, Lyon, pp 9-112
31. Wong JS, Kaelin CM, Troyan SL et al. (2006) Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol 24: 1031-1036